Thailand says it’s not ‘fast spinning out of Covid-19 control’
With reference to your article Thailand fast spinning out of Covid-19 control published on May 13, 2021, I feel compelled to set the record straight as follows.
The article’s claim that AstraZeneca has chosen Siam Bioscience to produce its vaccine was based on “unknown reasons” is false. Many companies in Thailand participated in the bidding process but Siam Bioscience was the successful bidder because of its capability for the transfer of viral vector vaccine manufacturing technology and its capacity to produce over 200 million doses per year.
